EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Nirmatrelvir-ritonavir significantly reduces severe COVID-19 outcomes in diverse Taiwanese populations: Comprehensive evidence from a large-scale longitudinal cohort study in Taiwan

Fu-Der Wang, Yu-Hui Chang, Han-Chuan Chuang, Tsong-Yih Ou, Mei-Hui Lee, Phung-Anh Nguyen, Thanh Phuc Phan, Whitney Burton, Thi Kim Hien Nguyen, Min-Huei Hsu, Shiue-Ming Lin, Chieh Yang und 1 weitere

Journal of Infection and Public Health · 2025

DOI: 10.1016/j.jiph.2025.102760 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Infection and Public Health, 2025. Verfasst von Fu-Der Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan; Institute of Public Health, Nat…. Hauptthemen laut MEDLINE: Ritonavir, COVID-19 Drug Treatment, COVID-19, Antiviral Agents. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RitonavirCOVID-19 Drug TreatmentCOVID-19Antiviral AgentsHumansTaiwanMaleFemaleMiddle AgedRetrospective StudiesAgedLongitudinal StudiesAdultTreatment OutcomeSARS-CoV-2Drug Combinations

Stichwörter der Autor:innen

COVID-19Nirmatrelvir-RitonavirTaiwaneffectivenessoutcomereal-world evidence

Substanzen

RitonavirAntiviral AgentsDrug Combinations

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan; Institute of Public Health, National Yang-Ming Chiao-Tung University, Taipei, Taiwan.
  • School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.
  • Division of Infectious Diseases, Department of Internal Medicine, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan.
  • Division of Infectious Diseases, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
  • Division of Infectious Diseases, Department of Internal Medicine, Shuang Ho Hospital, New Taipei City, Taipei Medical University, Taipei, Taiwan.
  • Graduate Institute of Data Science, College of Management, Taipei Medical University, Taipei City, Taiwan; Clinical Data Center, Office of Data Science, Taipei Medical University, Taipei, Taiwan; Clinical Big Data Resea…

Förderung

  • National Science and Technology Council

Zitieren

APA

Wang, F. D., Chang, Y. H., Chuang, H. C., Ou, T. Y., Lee, M. H., Nguyen, P. A., Phan, T. P., Burton, W., Nguyen, T. K. H., Hsu, M. H., Lin, S. M., Yang, C., & Hsu, J. C. (2025). Nirmatrelvir-ritonavir significantly reduces severe COVID-19 outcomes in diverse Taiwanese populations: Comprehensive evidence from a large-scale longitudinal cohort study in Taiwan. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2025.102760

Vancouver

Wang FD, Chang YH, Chuang HC, Ou TY, Lee MH, Nguyen PA, et al. Nirmatrelvir-ritonavir significantly reduces severe COVID-19 outcomes in diverse Taiwanese populations: Comprehensive evidence from a large-scale longitudinal cohort study in Taiwan. Journal of Infection and Public Health. 2025. doi:10.1016/j.jiph.2025.102760

BibTeX
@article{Wang2025,
  author = {Wang, Fu-Der and Chang, Yu-Hui and Chuang, Han-Chuan and Ou, Tsong-Yih and Lee, Mei-Hui and Nguyen, Phung-Anh and Phan, Thanh Phuc and Burton, Whitney and Nguyen, Thi Kim Hien and Hsu, Min-Huei and Lin, Shiue-Ming and Yang, Chieh and Hsu, Jason C},
  title = {Nirmatrelvir-ritonavir significantly reduces severe COVID-19 outcomes in diverse Taiwanese populations: Comprehensive evidence from a large-scale longitudinal cohort study in Taiwan},
  journal = {Journal of Infection and Public Health},
  year = {2025},
  doi = {10.1016/j.jiph.2025.102760}
}
Kostenlos starten →